HomeInterlock Medizintechnik GmbHInterlock & Key Surgical Merge to Create Leading Global Provider of Sterile Processing & OR Supplies

Interlock & Key Surgical Merge to Create Leading Global Provider of Sterile Processing & OR Supplies


Interlock and Key Surgical merge to create leading global provider of sterile processing and operating room supplies announced today.

Interlock Medizintechnik GmbH and Key Surgical, Inc. announced today that they have merged to create one of the world’s leading providers of sterile processing and operating room supplies.

The newly combined company also gains products from Clinipak Ltd., a United Kingdom provider acquired by Interlock last year. Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, led the merger of the European and U.S. providers and invested in the newly combined company.

Interlock is a leading European provider to central sterile supply departments. Clinipak is a manufacturer and distributor of central sterile supplies in the United Kingdom. Key Surgical has grown to become a premier U.S. provider of products that clean, protect and identify surgical instruments since it was founded in 1988. As one company, Interlock, Clinipak and Key Surgical will offer a broad range of sterile processing and operating room products and supplies to nearly 10,000 hospitals and surgical centres around the world.

Mads Fiig, managing director, European operations, Interlock, said: “We are tremendously excited about the combination of our companies and the benefits it will bring to our customers. Interlock, Clinipak and Key Surgical are highly regarded throughout Europe and the United Stated for our expertise, broad product offering and exceptional customer service. Together, we will offer hospitals and surgical centres a comprehensive portfolio of products and supplies that support the industry’s highest quality standards for patient care and safety in the surgical setting.”

Gerhard Baum, co-founder of Interlock, added: “We have the unique opportunity to bring together three highly respected, high-quality brands that are market leaders in their respective countries. As one entity, Interlock, Clinipak and Key Surgical will be the only global organisation dedicated to providing hospitals with products and supplies that support their goals for surgical and patient safety. In addition, our partnership with Water Street will allow us to gain access to a highly regarded team with deep medical product and distribution expertise and a network of resources to support our growth.”

Scot Milchman, CEO of Key Surgical, added, “It’s clear that increasing numbers of hospitals are investing in infection prevention and patient safety initiatives. The combination of Interlock, Clinipak and Key Surgical creates a strong and extensive global platform for us to build on. We plan to work together to invest in the company’s infrastructure and pursue acquisition opportunities that will strategically expand our product portfolio and geographic footprint.”

Mr. Milchman will serve as CEO of the newly combined company, Brian O’Connell as president and COO, and John Savage as CFO. Mr. Fiig, a longtime healthcare executive, will serve as managing director of European operations. Mr. Baum, one of the founders of Interlock, will remain with the company to focus on customer and supplier relationships. Key Surgical, Interlock and Clinipak will continue to operate and serve customers under their existing names and brands.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy